← Browse by Condition
Medical Condition
cardiogenic shock
Total Trials
14
Recruiting Now
14
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for cardiogenic shock sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — cardiogenic shock Clinical Trials
How many clinical trials are currently recruiting for cardiogenic shock?
ClinicalMetric currently tracks 14 actively recruiting clinical trials for cardiogenic shock, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 14. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cardiogenic shock?
cardiogenic shock research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cardiogenic shock clinical trial?
Eligibility criteria for cardiogenic shock trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT06697093
Recruiting
Enrollment
500 pts
Location
Poland
Sponsor
Wroclaw Medical University
NCT04158479
Recruiting
Enrollment
20,000 pts
Location
China
Sponsor
Beijing Anzhen Hospital
NCT05586282
Recruiting
Enrollment
380 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT06792643 Phase 2
Recruiting
Enrollment
50 pts
Location
Italy
Sponsor
IRCCS San Raffaele
NCT07062744
Recruiting
Enrollment
108 pts
Location
Vietnam
Sponsor
Bach Mai Hospital
NCT04117230
Recruiting
Enrollment
1,500 pts
Location
Switzerland
Sponsor
Insel Gruppe AG, University Ho...
NCT06535503
Recruiting
Enrollment
400 pts
Location
United Arab Emirates
Sponsor
Abu Dhabi Health Services Comp...
NCT06572826
Recruiting
Enrollment
2,000 pts
Location
Italy
Sponsor
Fondazione Don Carlo Gnocchi O...
NCT07508891
Recruiting
Enrollment
1,000 pts
Location
Germany
Sponsor
Universitätsklinikum Hamburg-E...
NCT06644963
Recruiting
Enrollment
800 pts
Location
France
Sponsor
University Hospital, Montpelli...
NCT06475456
Recruiting
Enrollment
786 pts
Location
Italy
Sponsor
Fondazione GISE Onlus
NCT06162247
Recruiting
Enrollment
5,000 pts
Location
Italy
Sponsor
Federico II University
NCT05485376
Recruiting
Enrollment
400 pts
Location
United States
Sponsor
Tufts Medical Center
NCT07619144
Recruiting
Enrollment
100 pts
Location
Austria
Sponsor
Medical University of Vienna
Related Conditions
heart failure (2) acute heart failure (2) cardiac arrest (1) acute respiratory distress syndrome (1) acute respiratory failure (1) postresuscitation disease (1) septic shock (1) extracorporeal membrane oxygenation complication (1) platelet dysfunction (1) pulmonary artery catheter waveform interpretation (1) hemodynamic management (1) hemodynamic optimization (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology